Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Cancer Science|September 1, 2022
Paving the road to make chimeric antigen receptor-T-cell therapy effective against solid tumorsKeishi Adachi, Koji TamadaJournal of Gastroenterology|July 14, 2018
Microbial biomarkers for immune checkpoint blockade therapy against cancerKeishi Adachi, Koji TamadaGan to Kagaku Ryoho. Cancer & Chemotherapy|May 23, 2023
[Development of CAR-T Cells Effective against Solid Tumors]Keishi Adachi, Koji TamadaCancer Science|May 19, 2015
Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacyKeishi Adachi, Koji TamadaGan to Kagaku Ryoho. Cancer & Chemotherapy|April 13, 2016
[Genome-Based Biomarkers of Immune Checkpoint Blockade Therapy]Keishi Adachi, Koji TamadaProceedings of the National Academy of Sciences of the United States of America|January 6, 2011
T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cellsKeishi Adachi, Mark M DavisCancer Immunology, Immunotherapy : CII|February 7, 2026
CAR-T cells co-expressing IL-7 and CCL19 promote epitope spreading to enhance antitumor immunityKeishi Adachi, Yukimi Sakoda, Tsuneyasu Kaisho, et al.Cancer Science|August 22, 2019
Improved survival of chimeric antigen receptor-engineered T (CAR-T) and tumor-specific T cells caused by anti-programmed cell death protein 1 single-chain variable fragment-producing CAR-T cellsMasao Nakajima, Yukimi Sakoda, Keishi Adachi, et al.Cancer Medicine|April 9, 2023
Therapeutic effects of anti-GM2 CAR-T cells expressing IL-7 and CCL19 for GM2-positive solid cancer in xenograft modelTakahiro Sasaki, Yukimi Sakoda, Keishi Adachi, et al.Plos One|December 21, 2013
Unique T cells with unconventional cytokine profiles induced in the livers of mice during Schistosoma mansoni infectionKeishi Adachi, Yoshio Osada, Risa Nakamura, et al.Pageof 3